Drawing for PYRTAVO

USPTO serial 85827702

PYRTAVO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PHAM, LANA H
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PYRTAVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

CHRISTOPHER M. HANES GLAXOSMITHKLINEFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; (Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 6, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 5, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 29, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 28, 2015EX5GSOU EXTENSION 5 GRANTED—
Dec 21, 2015EXT5SOU EXTENSION 5 FILED—
Dec 21, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2015EX4GSOU EXTENSION 4 GRANTED—
Jun 23, 2015EXT4SOU EXTENSION 4 FILED—
Jun 23, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 23, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 16, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 15, 2014EX3GSOU EXTENSION 3 GRANTED—
Dec 12, 2014EXT3SOU EXTENSION 3 FILED—
Dec 12, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 22, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 21, 2014EX2GSOU EXTENSION 2 GRANTED—
Jul 15, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 24, 2014EXT2SOU EXTENSION 2 FILED—
Jun 24, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 29, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 27, 2014EX1GSOU EXTENSION 1 GRANTED—
Jan 27, 2014EXT1SOU EXTENSION 1 FILED—
Jan 27, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 4, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2013FIXDELECTRONIC RECORD REVIEW COMPLETE—
Apr 26, 2013ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 18, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2013DOCKASSIGNED TO EXAMINER—
Mar 25, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 25, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 23, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance